--- title: "NEW ENGLAND BIOLABS, INC. — Capability Statement" uei: "EDKJNT8DADG8" cage: "00UJ1" canonical: "https://teamingindex.com/contractor/EDKJNT8DADG8/capability.md" html_url: "https://teamingindex.com/contractor/EDKJNT8DADG8" updated: "2026-11-09T17:28:18.052Z" generator: "TeamingIndex capability twin 1.0" legal_name: "NEW ENGLAND BIOLABS, INC." dba_name: "NEW ENGLAND BIOLABS INC" primary_naics: "325414" sam_status: "active" active_exclusion: false claimed: false tier: "unclaimed" --- # NEW ENGLAND BIOLABS, INC. > NEW ENGLAND BIOLABS, INC. (DBA NEW ENGLAND BIOLABS INC) is a SAM.gov-registered entity based in IPSWICH, MA 01938-2723. UEI EDKJNT8DADG8; CAGE 00UJ1; primary NAICS 325414. Compliance posture not provided. Active SAM registration. > **Unclaimed profile:** seeded from SAM.gov and USAspending public records. The entity has not claimed it, so capabilities and compliance posture have not been provided. ## Identifiers - **Legal business name:** NEW ENGLAND BIOLABS, INC. - **DBA name:** NEW ENGLAND BIOLABS INC - **UEI (SAM.gov Unique Entity ID):** EDKJNT8DADG8 - **CAGE code:** 00UJ1 - **Entity structure:** Corporate Entity (Not Tax Exempt) - **State of incorporation:** MA - **Website:** - **TeamingIndex profile:** - **Profile status:** Unclaimed · seeded from SAM.gov and USAspending public records ## Location - **Physical address (city, state, ZIP):** IPSWICH, MA 01938-2723 - **Country:** United States - **Congressional district:** MA-06 ## NAICS & PSC | NAICS | Title | Primary | Small under SBA size standard (SAM.gov) | | --- | --- | --- | --- | | 325414 | Biological Product (except Diagnostic) Manufacturing | Yes | Yes | | 541714 | Research and Development in Biotechnology (except Nanobiotechnology) | No | Yes | | PSC | Name | | --- | --- | | 6640 | LABORATORY EQUIPMENT AND SUPPLIES | - **PSC names:** Acquisition.gov PSC Manual (April 2025 edition) Size status is NAICS-specific and reflects the entity’s SAM.gov representations; check it against the size standard of the solicitation’s NAICS code. ## Socio-economic status - Small Business (SB) Source: SAM.gov entity registration, synced 2026-11-09. Confirm current SBA certification (8(a), HUBZone, WOSB/EDWOSB, VetCert SDVOSB/VOSB) before relying on a status for a set-aside. ## SAM registration & exclusion screening - **Registration:** Active SAM registration - **Registration expires:** 2027-06-08 - **Registration activated:** 2026-06-18 - **Exclusion screening (FAR subpart 9.4):** No active exclusion recorded in SAM.gov - **Teaming eligibility:** Eligible to be proposed as a team member (active registration, no exclusion) - **Source:** SAM.gov Entity Management, synced 2026-11-09 ## Compliance posture Compliance posture not provided by the contractor. - Facility clearance: visible to paid members - Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). ## Contract vehicles No contract vehicle holdings on file. ## Past performance - **Total obligated, trailing 36 months (USAspending.gov):** $378,591 - **Award history:** 13 awards on record - **Top funding agencies:** National Institutes of Health; Smithsonian Institution Showing the 10 most recent of 13 awards. | Award PIID | Agency | NAICS / PSC | Obligated | Base + all options | Period of performance | Set-aside | Place of performance | Description | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 75N98026P01401 | Department of Health and Human Services / National Institutes of Health | 334516 / 6505 | $59,478 | — | 2026-09-02 → 2027-09-01 | — | MA | NEW ENGLAND BIOLABS:1105931 \[26-002792\] | | 33315225P00527670 | Smithsonian Institution / Smithsonian Institution | 325414 / 6640 | $13,281 | — | 2025-08-05 → 2025-09-30 | — | DC | SCIENTIFIC SUPPLIES | | 75N92E25P00172 | Department of Health and Human Services / National Institutes of Health | 325414 / 6505 | $0 | — | 2025-05-30 → 2025-08-29 | — | MD | THESE REAGENTS ARE NEEDED BY CASANDRA MONTEMAYOR FOR PREPARATION OF METAGENOMIC LIBRARIES FOR SEQUENCING FOR DR. MARK COOKSON. THE REAGENTS BEING ORDERED WILL SUPPORT THE COOKSON… | | 75N93025P00087 | Department of Health and Human Services / National Institutes of Health | 325414 / 6505 | $19,883 | — | 2024-11-25 → 2025-06-30 | — | MA | DNA AND RNA LIBRARY PREP KITS FOR ILLUMINA | | 75N93025P00902 | Department of Health and Human Services / National Institutes of Health | 325414 / 6640 | $11,724 | — | 2025-04-11 → 2025-05-30 | — | MA | NEB PCR REAGENTS AND BIOLOGICALS (AMBIS \#2259094) | | 75N92E25P00081 | Department of Health and Human Services / National Institutes of Health | 325414 / 6550 | $0 | — | 2025-03-20 → 2025-05-20 | — | MA | NEBNEXT ULTRA 2 DIRECTIONAL RNA LIBRARY PREP WITH PURIFICATION BEADS | | 75N92024P00141 | Department of Health and Human Services / National Institutes of Health | 325413 / 6550 | $38,892 | — | 2024-04-19 → 2025-04-19 | — | MA | NEB NEXT ULTRA II DIRECTIONAL RNA LIBRARY PREP. | | 75N95024P00179 | Department of Health and Human Services / National Institutes of Health | 325414 / 6505 | $158,885 | — | 2024-03-18 → 2025-02-28 | — | MA | ENZYMATIC KITS FOR SEQUENCING | | 75N92B25F90004 (order under 75N98024A00061) | Department of Health and Human Services / National Institutes of Health | 325414 / 6505 | $12,760 | — | 2024-12-11 → 2025-01-31 | — | MA | NEW ENGLAND BIOLABS:1105931 \[25-000749\] 01-NEBNEXT GLOBIN & RRNA DEPLETION KIT (HUMAN/MOUSE/RAT) 96 REACTIONS 02-NEBNEXT MULTIPLEX OLIGOS FOR ILLUMINA (96 INDEX PRIMERS)… | | 75N92B24P00048 | Department of Health and Human Services / National Institutes of Health | 325414 / 6810 | $17,225 | — | 2024-01-21 → 2025-01-20 | — | MA | NEW ENGLAND BIOLABS KITS FOR FOR RNA-SEQ | ## Proven teaming graph - As a subcontractor: 1 prime contractor, 1 reported sub-award, $51.9K total - Subcontractor to THE JOHNS HOPKINS UNIVERSITY (UEI FTMTDMBR29C7): 1 reported sub-award; $51,855 total; latest Dec 18, 2025; agencies: National Institutes of Health - Source: USAspending.gov sub-award reports (FSRS), as of Nov 9, 2026. Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values. ## SBIR/STTR portfolio - SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects - 44 SBIR/STTR awards totaling $13.5M: SBIR Phase I 27, SBIR Phase II 12, STTR Phase I 3, STTR Phase II 2 - By agency: Department of Health and Human Services 43, National Science Foundation 1 - STTR Phase I, Department of Health and Human Services (National Institutes of Health), 2013: Structure guided rational engineering of novel DNA reagents. ($99,781) - SBIR Phase I, Department of Health and Human Services (National Institutes of Health), 2013: Novel 5-methylcytosine Oxidases ($251,006) - STTR Phase II, Department of Health and Human Services (National Institutes of Health), 2013: Structure guided rational engineering of novel DNA reagents. ($761,592) - SBIR Phase II, Department of Health and Human Services (National Institutes of Health), 2013: Studies of DNA Methyltransferases ($1,002,120) - SBIR Phase I, Department of Health and Human Services (National Institutes of Health), 2012: NOVEL 5-HYDROXYMETHYLCYTOSINE SPECIFIC ENZYMES FOR EPIGENETIC STUDIES. ($278,797) - SBIR Phase I, Department of Health and Human Services (National Institutes of Health), 2012: FINDING NOVEL REAGENTS BY BIOINFORMATICS AND BIOCHEMISTRY ($218,685) - SBIR Phase I, Department of Health and Human Services (National Institutes of Health), 2012: Studies of DNA Methyltransferases ($256,651) - SBIR Phase II, Department of Health and Human Services (National Institutes of Health), 2012: In vitro Reconstitution of Protein Translation of Thermus Thermophilus for Direct ($960,499) - SBIR Phase II, Department of Health and Human Services (National Institutes of Health), 2012: NOVEL 5-HYDROXYMETHYLCYTOSINE SPECIFIC ENZYMES FOR EPIGENETIC STUDIES. ($640,759) - SBIR Phase II, Department of Health and Human Services (National Institutes of Health), 2012: FINDING NOVEL REAGENTS BY BIOINFORMATICS AND BIOCHEMISTRY ($874,892) - Phase III: Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual. - Source: SBIR.gov award data file, as of Nov 12, 2026 (file published Nov 1, 2026) ## FedRAMP offerings - No FedRAMP Marketplace listing is linked to this company - Source: FedRAMP Marketplace, sync date not recorded ## Exclusions & screening - Not yet checked against SAM.gov exclusions (search exclusions on SAM.gov: https://sam.gov/search/?index=ex) - Source: SAM.gov Exclusions, sync date not recorded - No confirmed match on the Consolidated Screening List (screened Nov 13, 2026) ## Contract vehicles on federal record - No contract-vehicle seats on federal record are linked to this company ## GSA CALC+ rates - No GSA CALC+ awarded ceiling rates on record for this company - Source: GSA CALC+ awarded ceiling rates, sync date not recorded. Ceiling rates are the most an agency can be charged, not prices paid ## Capabilities & differentiators No capability narrative published. ## Technical tags No technical tags published. ## Teaming preferences - Teaming preferences not published - **Teaming requests and NDAs:** request an introduction on the TeamingIndex profile (sign-in required): ## Business development contact No business-development contact published. ## Corporate hierarchy - No parent entity reported in SAM.gov - Affiliation with a parent or sister concerns can affect small-business size status (13 CFR 121.103). ## Provenance & disclaimer - **SAM.gov entity registration** (identifiers, NAICS/PSC, size and socio-economic status, hierarchy, registration and exclusion status): synced 2026-11-09 - **USAspending.gov** (prime award history and trailing 36-month obligations): nightly sync - **Contractor-provided profile** (capabilities, teaming preferences, self-attested compliance): not provided - **TeamingIndex verification** (credentials marked “Verified by TeamingIndex”): no verified credentials on record; methodology: - **Blind SPRS:** exact NIST SP 800-171 SPRS scores are published only when the contractor opts in; brackets are cumulative thresholds (SPRS ≥ 0, SPRS ≥ 50, SPRS ≥ 70, SPRS ≥ 85, SPRS ≥ 95, SPRS ≥ 105, SPRS = 110 (perfect)). - **Before award:** self-attested facts have not been independently verified. Confirm registration and exclusions in SAM.gov, CMMC status and SPRS assessment currency with the contractor (DFARS 252.204-7019, -7020 and -7021), facility clearances through DCSA’s NISS, AS9100-series certificates in the IAQG OASIS database, and FedRAMP authorizations on the FedRAMP Marketplace. - **Zero CUI:** this document contains no Controlled Unclassified Information. TeamingIndex stores verification metadata only, never SSPs, POA&Ms or DD Form 254s. - **Machine-readable:** schema.org JSON-LD is embedded in ; this twin: ; site index: © 2026 HILARTECH, LLC. All rights reserved. TeamingIndex.com is an independent defense industrial base intelligence platform owned and operated by HILARTECH, LLC and is not affiliated with or endorsed by the U.S. Department of Defense (DoD), the General Services Administration (GSA), or SAM.gov.